Franklin Templeton Investments · 2020-02-25 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$2.1M | — | — | $27.9M | 每日估算 |
| 2026-07-30 | +$380,518 | — | — | $29.3M | 每日估算 |
| 2026-07-29 | -$201,990 | — | — | $29.1M | 每日估算 |
| 2026-07-28 | +$1.2M | — | — | $29.1M | 每日估算 |
| 2026-07-27 | +$86,015 | — | — | $27.9M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
GH Guardant Health Inc COM | EC | 15,718 | $1.5M | 6.77% |
NTRA Natera Inc. COM | EC | 7,131 | $1.4M | 6.65% |
KRYS Krystal Biotech Inc COM | EC | 4,418 | $1.1M | 5.32% |
UTHR United Therapeutics Corporation COM | EC |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified、category_reclassified_by_current_taxonomy。
| 每日估算 |
| 2026-07-26 | -$1.2M | — | — | $27.9M | 每日估算 |
| 2026-07-25 | +$89,998 | — | — | $29.2M | 每日估算 |
| 2026-03-31 | $0 | $0 | $0 | $21.4M | SEC 月度 |
| 2026-02-28 | $0 | $0 | $0 | — | SEC 月度 |
| 2026-01-31 | +$1.9M | $1.9M | $0 | — | SEC 月度 |
| 1,680 |
| $996,206 |
| 4.64% |
INSM Insmed Inc COM PAR $.01 | EC | 5,932 | $970,001 | 4.52% |
BBIO Bridgebio Pharma Inc COM | EC | 12,192 | $905,378 | 4.22% |
LGND Ligand Pharmaceuticals Incorporated COM NEW | EC | 3,794 | $757,472 | 3.53% |
AZN AstraZeneca PLC ORD USD0.25 | EC | 3,695 | $728,728 | 3.40% |
ADPT Adaptive Biotechnologies Corp COM | EC | 48,245 | $669,641 | 3.12% |
VRTX Vertex Pharmaceuticals Incorporated COM | EC | 1,435 | $640,785 | 2.99% |
207940 Samsung Biologics Co Ltd KRW2500 | EC | 652 | $640,230 | 2.99% |
MEDP Medpace Holdings Inc. COM | EC | 1,327 | $637,212 | 2.97% |
REGN Regeneron Pharmaceuticals, Inc. COM | EC | 748 | $577,935 | 2.69% |
CTVA Corteva Inc COM | EC | 6,904 | $577,934 | 2.69% |
ALNY Alnylam Pharmaceuticals Inc. COM | EC | 1,687 | $558,178 | 2.60% |
LLY Eli Lilly & Co. COM | EC | 593 | $545,424 | 2.54% |
IONS Ionis Pharmaceuticals, Inc. COM | EC | 5,957 | $447,311 | 2.09% |
TEM Tempus AI Inc. CL A | EC | 8,726 | $394,590 | 1.84% |
BNTX BioNTech SE SPONSORED ADS | EC | 4,340 | $385,739 | 1.80% |
NBIX Neurocrine Biosciences Inc COM | EC | 2,693 | $354,776 | 1.65% |
STOK Stoke Therapeutics Inc COM | EC | 10,539 | $343,150 | 1.60% |
TWST Twist Bioscience Corporation COM | EC | 7,184 | $341,384 | 1.59% |
ARGX Argenx SE EUR0.10 | EC | 459 | $328,316 | 1.53% |
PTCT PTC Therapeutics, Inc. COM | EC | 4,652 | $316,941 | 1.48% |
TVTX Travere Therapeutics Inc COM | EC | 10,129 | $300,933 | 1.40% |
CRL Charles River Laboratories International, Inc. COM | EC | 1,445 | $249,263 | 1.16% |
CRSP CRISPR Therapeutics AG NAMEN AKT | EC | 4,671 | $222,199 | 1.04% |
RGEN Repligen Corporation COM | EC | 1,866 | $219,852 | 1.03% |
VCYT Veracyte Inc COM | EC | 6,788 | $218,641 | 1.02% |
PRAX Praxis Precision Medicines Inc COM NEW | EC | 667 | $214,901 | 1.00% |
GRAL GRAIL Inc COM | EC | 4,138 | $213,852 | 1.00% |
SRT3 Sartorius AG NON VTG PFD NPV | EP | 841 | $205,331 | 0.96% |
DHR Danaher Corporation COM | EC | 1,050 | $199,080 | 0.93% |
TMO Thermo Fisher Scientific Inc COM | EC | 391 | $192,188 | 0.90% |
IQV IQVIA Holdings Inc. COM | EC | 1,005 | $171,393 | 0.80% |
BEAM Beam Therapeutics Inc. COM | EC | 7,036 | $167,668 | 0.78% |
JAZZ Jazz Pharmaceuticals PLC SHS USD | EC | 841 | $158,991 | 0.74% |
CPRX Catalyst Pharmaceuticals Inc. COM | EC | 6,375 | $157,845 | 0.74% |
CDNS Cadence Design Systems, Inc. COM | EC | 545 | $151,439 | 0.71% |
A Agilent Technologies Inc. COM | EC | 1,136 | $129,481 | 0.60% |
CDNA Caredx Inc COM | EC | 7,429 | $128,967 | 0.60% |
QGEN QIAGEN NV ORD SHARES | EC | 3,175 | $127,127 | 0.59% |
ANAB AnaptysBio Inc. COM | EC | 2,041 | $113,194 | 0.53% |
0126Z0 Samsung Epis Holdings KRW2500 | EC | 350 | $112,885 | 0.53% |
TARS Tarsus Pharmaceuticals Inc COM | EC | 1,487 | $104,313 | 0.49% |
RARE Ultragenyx Pharmaceuticals Inc COM | EC | 4,765 | $99,827 | 0.47% |
ARQT Arcutis Biotherapeutics Inc. COM | EC | 4,107 | $96,761 | 0.45% |
AXSM Axsome Therapeutics Inc. COM | EC | 566 | $95,665 | 0.45% |
WGS GeneDx Holdings Corp COM CL A | EC | 1,409 | $90,486 | 0.42% |
RYTM Rhythm Pharmaceuticals Inc COM | EC | 974 | $84,709 | 0.39% |
HNGE Hinge Health, Inc. CL A | EC | 2,182 | $84,138 | 0.39% |
BMY Bristol-Myers Squibb Company COM | EC | 1,111 | $67,382 | 0.31% |
BIO Bio-Rad Laboratories, Inc. CL A | EC | 226 | $62,998 | 0.29% |
ONC BeOne Medicines Ltd. SPONSORED ADS | EC | 209 | $62,067 | 0.29% |
TMDX TransMedics Group Inc. COM | EC | 482 | $47,916 | 0.22% |
NGNE Neurogene Inc. COM | EC | 1,840 | $37,094 | 0.17% |
WVE Wave Life Sciences Ltd. SHS | EC | 4,470 | $32,408 | 0.15% |
RXRX Recursion Pharmaceuticals Inc CL A | EC | 10,393 | $31,907 | 0.15% |
CAI Caris Life Sciences Inc. COM | EC | 557 | $9,959 | 0.05% |
2200964D OmniAb Inc. USD0.0001 A (USD15 VESTING) | EC | 240 | $0 | 0.00% |
2200963D OmniAb Inc. USD0.0001 A (USD12.5 VESTING) | EC | 240 | $0 | 0.00% |